DeepMed Research

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Resveratrol and Midazolam Metabolism

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Midazolam
Dietary Supplement: resveratrol (multiple dose)
Dietary Supplement: resveratrol (single dose)

First Posted Date: 2010-08-02

Last Posted Date: 2017-10-31

Lead Sponsor: University of Washington

Target Recruit Count: 6

Registration Number: NCT01173640

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Improving Communication During Pediatric Visits for Acute Respiratory Illness

Not Applicable

Completed

Conditions: Upper Respiratory Infection

Interventions: Behavioral: Physician Workshop

First Posted Date: 2010-07-23

Last Posted Date: 2010-07-23

Lead Sponsor: University of Washington

Target Recruit Count: 1313

Registration Number: NCT01168778

ORAL T-8 Oral Testosterone for Male Hormonal Contraception

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Oral Testosterone
Drug: Acyline

First Posted Date: 2010-07-22

Last Posted Date: 2013-09-06

Lead Sponsor: University of Washington

Target Recruit Count: 14

Registration Number: NCT01167829

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)

Completed

Conditions: Ovarian Cancer
Breast Cancer

First Posted Date: 2010-07-22

Last Posted Date: 2022-02-03

Lead Sponsor: University of Washington

Target Recruit Count: 31

Registration Number: NCT01167842

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma

Phase 1

Completed

Conditions: Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Adult Hodgkin Lymphoma

Interventions: Drug: Bendamustine Hydrochloride
Drug: Carboplatin
Biological: Rituximab
Drug: Etoposide
Other: Laboratory Biomarker Analysis

First Posted Date: 2010-07-19

Last Posted Date: 2018-12-05

Lead Sponsor: University of Washington

Target Recruit Count: 48

Registration Number: NCT01165112

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Amputee Residual Limb Volume Fluctuation

Completed

Conditions: Amputation

Interventions: Other: Monitored for limb volume

First Posted Date: 2010-07-13

Last Posted Date: 2014-04-25

Lead Sponsor: University of Washington

Target Recruit Count: 28

Registration Number: NCT01161238

Locations: 🇺🇸
University of Washington, Bioengineering Department, Seattle, Washington, United States

A Practical Model to Transform Childhood Asthma Care - Spirometry Training in the Primary Care Setting

Not Applicable

Completed

Conditions: Asthma

Interventions: Behavioral: Virtually delivered spirometry quality improvement program

First Posted Date: 2010-07-13

Last Posted Date: 2010-07-13

Lead Sponsor: University of Washington

Target Recruit Count: 36

Registration Number: NCT01161433

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)

Not Applicable

Completed

Conditions: HIV

Interventions: Device: Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test

First Posted Date: 2010-07-13

Last Posted Date: 2017-06-07

Lead Sponsor: University of Washington

Target Recruit Count: 230

Registration Number: NCT01161446

Locations: 🇺🇸
Public Health - Seattle & King County STD Clinic, located at Harborview Medical Center, Seattle, Washington, United States

Mindfulness Based Relapse Prevention: Efficacy and Mechanisms

Phase 1

Completed

Conditions: Substance Use Disorders

Interventions: Behavioral: Mindfulness Based Relapse Prevention
Behavioral: Relapse Prevention
Behavioral: Treatment as Usual

First Posted Date: 2010-07-09

Last Posted Date: 2016-08-15

Lead Sponsor: University of Washington

Target Recruit Count: 286

Registration Number: NCT01159535

Locations: 🇺🇸
Recovery Centers of King County, Seattle, Washington, United States

L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer

Not Applicable

Completed

Conditions: Mucositis
Oral Complications of Chemotherapy
Oral Complications of Radiation Therapy
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
Recurrent Basal Cell Carcinoma of the Lip
Recurrent Lymphoepithelioma of the Nasopharynx
Recurrent Lymphoepithelioma of the Oropharynx
Recurrent Mucoepidermoid Carcinoma of the Oral Cavity
Recurrent Salivary Gland Cancer
Recurrent Squamous Cell Carcinoma of the Hypopharynx

Interventions: Procedure: quality-of-life assessment
Procedure: management of therapy complications
Dietary Supplement: L-lysine

First Posted Date: 2010-07-02

Last Posted Date: 2013-05-17

Lead Sponsor: University of Washington

Target Recruit Count: 10

Registration Number: NCT01155609

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy